Opioid Use Disorder (OUD) Market Size, Share, Growth | Global Industry Research Report, 2019-2026
SKU ID : FBUIN-15633646 | Publishing Date : 01-Apr-2020
Opioid Use Disorder (OUD) market size is valued at 1.98 Bn US$ and will increase to 4.5 Bn US$ in 2026, with a CAGR of 10.8% during forecast period.
Global Opioid Use Disorder (OUD) market competition by top manufacturers, with production, price, and revenue (value) and market share for each manufacturer; the
TOP PLAYERS including
Indivior PLC
Alkermes
Orexo US, Inc.
Titan Pharmaceuticals Inc.
TEVA PHARMACEUTICALS USA, INC
Mallinckrodt.
BioDelivery Sciences International Inc.
Mylan
Pfizer Inc.
Hikma Pharmaceuticals
Camurus
Market Segment:
By Drug Class
Buprenorphine
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
Market Segment by Application
By Distribution Channel
Hospitals Pharmacies
Retail Pharmacies & Stores
Online Pharmacies
Key Regions
split in this report: breakdown data for each region.Global
In this study, the years considered to estimate the market size of Opioid Use Disorder (OUD) are as follows:
Base Year:
2018Forecast Year:
2019-2026Key Questions Answered:
What is the market size and growth rate of the global and regional market by various segment?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What factors are estimated to drive and restrain the market growth?
What are the key technologies and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market growth?
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region